Statins When Merck's cholesterol-lowering statin mevacor was approved by the U.S. Food and Drug Administration (FDA) in 1987, the understanding of the link between cholesterol and heart disease was improving, and the potential market for the drug became significant. Subsequently, several other companies developed similar drugs: Merck produced zocor and crestor (rosuvastatin), Pfizer made lipitor (atorvastatin), Bristol-Myers Squibb produced pravachol , and Novartis developed lescol . Others include pitavastatin (Livalo).
Statins When Merck's cholesterol-lowering statin Mevacor (lovastatin) was approved by the U.S. Food and Drug Administration (FDA) in 1987, the understanding of the link between cholesterol and heart disease was improving, and the potential market for the drug became significant. Subsequently, several other companies developed similar drugs: Merck developed Zocor (simvastatin) and Crestor (rosuvastatin), Pfizer developed Lipitor (atorvastatin), Bristol-Myers Squibb developed Pravachol (pravastatin) , and Novartis developed Lescol (fluvastatin) . Others include pitavastatin (Livalo).
R
mevacor
Mevacor (lovastatin)
R
produced zocor and crestor
developed Zocor (simvastatin) and Crestor
R
made lipitor
developed Lipitor
R
produced pravachol
developed Pravachol (pravastatin)
R
lescol
Lescol (fluvastatin)